CN103193725A - (2r,3r)-2-[(1r)-1-[3,5-双(三氟甲基)苯基]乙氧基]-3-(4-氟苯基)吗啉盐的制法 - Google Patents
(2r,3r)-2-[(1r)-1-[3,5-双(三氟甲基)苯基]乙氧基]-3-(4-氟苯基)吗啉盐的制法 Download PDFInfo
- Publication number
- CN103193725A CN103193725A CN2013101277106A CN201310127710A CN103193725A CN 103193725 A CN103193725 A CN 103193725A CN 2013101277106 A CN2013101277106 A CN 2013101277106A CN 201310127710 A CN201310127710 A CN 201310127710A CN 103193725 A CN103193725 A CN 103193725A
- Authority
- CN
- China
- Prior art keywords
- acid
- solvent
- compound
- formula
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2013101277106A CN103193725A (zh) | 2013-04-12 | 2013-04-12 | (2r,3r)-2-[(1r)-1-[3,5-双(三氟甲基)苯基]乙氧基]-3-(4-氟苯基)吗啉盐的制法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2013101277106A CN103193725A (zh) | 2013-04-12 | 2013-04-12 | (2r,3r)-2-[(1r)-1-[3,5-双(三氟甲基)苯基]乙氧基]-3-(4-氟苯基)吗啉盐的制法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103193725A true CN103193725A (zh) | 2013-07-10 |
Family
ID=48716561
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2013101277106A Pending CN103193725A (zh) | 2013-04-12 | 2013-04-12 | (2r,3r)-2-[(1r)-1-[3,5-双(三氟甲基)苯基]乙氧基]-3-(4-氟苯基)吗啉盐的制法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103193725A (zh) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001096319A1 (en) * | 2000-06-09 | 2001-12-20 | Merck & Co., Inc. | Trans-glycosidation process for the synthesis of (2r, 2-alpha-r, 3a)-2-[1-(3,5-bis(trifluoromethyl)phenyl)ethoxy]-3-(4-fluorophenyl)-1,4-oxazine |
WO2007044829A2 (en) * | 2005-10-06 | 2007-04-19 | Dr. Reddy's Laboratories Ltd. | Preparation of aprepitant |
WO2010092591A2 (en) * | 2008-06-30 | 2010-08-19 | Usv Limited | Novel crystalline polymorphs of 5-[[(2r,3s)-2-[(1r)-1-[3,5- bis(trifluoromethyl) phenyl] ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2- dihydro-3h-1,2,4-triazol-3-one and process for preparation thereof |
CN101959870A (zh) * | 2008-02-26 | 2011-01-26 | 桑多斯股份公司 | 吗啉衍生物的制备 |
CN102295611A (zh) * | 2010-05-24 | 2011-12-28 | 成都地奥制药集团有限公司 | 一种神经激肽1受体拮抗剂类药物的合成方法 |
WO2012146692A1 (en) * | 2011-04-29 | 2012-11-01 | Sandoz Ag | Novel intermediates for the preparation of highly pure aprepitant or fosaprepitant |
-
2013
- 2013-04-12 CN CN2013101277106A patent/CN103193725A/zh active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001096319A1 (en) * | 2000-06-09 | 2001-12-20 | Merck & Co., Inc. | Trans-glycosidation process for the synthesis of (2r, 2-alpha-r, 3a)-2-[1-(3,5-bis(trifluoromethyl)phenyl)ethoxy]-3-(4-fluorophenyl)-1,4-oxazine |
WO2007044829A2 (en) * | 2005-10-06 | 2007-04-19 | Dr. Reddy's Laboratories Ltd. | Preparation of aprepitant |
CN101959870A (zh) * | 2008-02-26 | 2011-01-26 | 桑多斯股份公司 | 吗啉衍生物的制备 |
WO2010092591A2 (en) * | 2008-06-30 | 2010-08-19 | Usv Limited | Novel crystalline polymorphs of 5-[[(2r,3s)-2-[(1r)-1-[3,5- bis(trifluoromethyl) phenyl] ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2- dihydro-3h-1,2,4-triazol-3-one and process for preparation thereof |
CN102295611A (zh) * | 2010-05-24 | 2011-12-28 | 成都地奥制药集团有限公司 | 一种神经激肽1受体拮抗剂类药物的合成方法 |
WO2012146692A1 (en) * | 2011-04-29 | 2012-11-01 | Sandoz Ag | Novel intermediates for the preparation of highly pure aprepitant or fosaprepitant |
Non-Patent Citations (1)
Title |
---|
CHANDRASHEKAR R. ELATI,等: "A convergent approach to the synthesis of aprepitant: a potent human NK-1 receptor antagonist", 《TETRAHEDRON LETTERS》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101535272B (zh) | 制备美托咪啶及其盐的方法 | |
JP5188501B2 (ja) | モンテルカストおよびそのアミン塩類の精製方法 | |
WO2017076293A1 (zh) | 一种噁唑烷酮中间体的制备方法 | |
CN109912508B (zh) | 一种右美托咪定及其盐酸盐的制备方法 | |
JP2019505499A (ja) | ボリコナゾール中間体及びボリコナゾールの合成方法 | |
TW200936574A (en) | New process | |
CN1972901A (zh) | (z)-1-苯基-1-二乙氨基羰基-2-氨甲基环丙烷盐酸盐的制造方法 | |
JP2007302666A (ja) | モンテルカストおよびその前駆体の合成方法 | |
WO2015111085A2 (en) | Processes for the preparation of eltrombopag and pharmaceutically acceptable salts, solvates and intermediates thereof | |
CN103193725A (zh) | (2r,3r)-2-[(1r)-1-[3,5-双(三氟甲基)苯基]乙氧基]-3-(4-氟苯基)吗啉盐的制法 | |
US20130109853A1 (en) | Preparation method of 5-[[2(r)-[1(r)-[3,5-bis(trifluoromethyl) phenyl]ethoxy]-3(s)-4-fluorophenyl-4-morpholinyl]methyl]-1,2-dihydro-3h-1,2,4-triazole-3-one | |
JP6027910B2 (ja) | 触媒の製造方法、及び光学活性アンチ−1,2−ニトロアルカノール化合物の製造方法 | |
CN108456198A (zh) | 维拉佐酮或其盐酸盐的制备方法 | |
CN105175365A (zh) | 一种高效合成具有特定构型的β-苄基丁内酯的方法 | |
CN103664743B (zh) | (3s, 4r)-3-胺基-4-甲基哌啶-1-羧酸叔丁酯的制备方法 | |
CN105330550A (zh) | 一种光学活性的1-环己基乙胺的制备方法 | |
CN103214426A (zh) | 阿瑞匹坦吗啉关键中间体或其盐的制法 | |
KR101253106B1 (ko) | 키랄 옥실레인을 이용한 시타글립틴 중간체의 제조방법 | |
CN101006044A (zh) | 对苯二甲醛的提纯方法 | |
CN103012264A (zh) | 3-取代氨基-六氢-1h-氮杂环庚烷的拆分方法 | |
CN112390738B (zh) | 依折麦布中间体化合物及依折麦布的合成方法 | |
JP6182507B2 (ja) | 2,3−ジハロゲノアニリンの製造方法 | |
CN101544597B (zh) | S-(-)-氨氯地平的制备方法 | |
CN111943904B (zh) | 一种神经激肽1受体拮抗剂关键中间体的精制方法 | |
WO2009045489A2 (en) | Process for the synthesis of cmhtp, a paliperidone intermediate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: CHINA STATE INSTITUTE OF PHARMACEUTICAL INDUSTRY Effective date: 20130917 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20130917 Address after: 200040 Beijing West Road, Shanghai, No. 1320, No. Applicant after: Shanghai Institute of pharmaceutical industry Applicant after: China State Institute of Pharmaceutical Industry Address before: 200040 Beijing West Road, Shanghai, No. 1320, No. Applicant before: Shanghai Institute of pharmaceutical industry |
|
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20130710 |